[1]
|
Miyakis, S., Lockshin, M.D., et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis Haemostasis, 4(2), 295-306.
|
[2]
|
Levine, J.S., Branch, D.W. and Rauch, J. (2002) The antiphospholipid syndrome. New England Journal of Medicine, 346(10), 752-763.
|
[3]
|
Wahl, D.G., Bounameaux, H., de Moerloose, P., et al. (2000) Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: Do the benefits outweight the risks? A decision analysis. Archives of Internal Medicine, 160(13), 2042-2048.
|
[4]
|
Ogimoto, A., Sekiya, M., Funada, J., et al. (2000) Anti- phospholipid syndrome with acute myocardial infarction and portal vein occlusion. Journal of Japanese Circulation, 64(6), 468-470.
|
[5]
|
Ikeda, Y., Yagi, S., Yamaguchi, H., et al. (2006) Intra- vascular ultrasound findings of diffuse coronary athero- sclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome. Circulation Journal, 70(8), 1082-1085.
|
[6]
|
Ruffatti, A., Montecucco, C., Volante, D., et al. (2000) Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. Rheumatology, 39(5), 565- 567.
|
[7]
|
Harris, E.N., Khamastha, M.A. and Hughes, G.R.D. (1993) Antiphospho-lipid antibody syndrome. In: McCarty, D.J. and Koopman, W.J., Eds., Arthritis and Allied Conditions, Lea and Febinger, Philadelphia, 1201-1212.
|